In conclusion, protein phosphorylation analysis demonstrated that increased Akt1/2/3 phosphorylation is characteristic for acquired cetuximab resistance in HNSCC cell lines. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.